Overall rank by patents
#675
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Takeda Pharmaceutical Company Limited
USPTO PatentsView assignee record — 668 granted patents across 61 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
668
Total patents granted
61
CPC technology areas
13.9
Avg claims per patent
+27%
5-year filing velocity
Portfolio overview
Takeda Pharmaceutical Company Limited has been granted 668 US utility patents between 2015 and 2025, placing Takeda Pharmaceutical Company Limited at rank #675 across all assignees tracked by PlainPatent. This portfolio spans 61 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Takeda Pharmaceutical Company Limited is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 64.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 374 grants, compared with 294 in the 2015–2019 window — a +27% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Takeda Pharmaceutical Company Limited's 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 61 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Takeda Pharmaceutical Company Limited against peers pursuing similar technology classes.
How does Takeda compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Takeda Pharmaceut… ◀ 668
Takeda Pharmaceutical Company Limited
668 patents
What this shows Takeda holds 668 patents — placing it at rank #675 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 67 | 10.0% |
| 2016 | 62 | 9.3% |
| 2017 | 61 | 9.1% |
| 2018 | 47 | 7.0% |
| 2019 | 57 | 8.5% |
| 2020 | 46 | 6.9% |
| 2021 | 52 | 7.8% |
| 2022 | 60 | 9.0% |
| 2023 | 70 | 10.5% |
| 2024 | 77 | 11.5% |
| 2025 | 69 | 10.3% |
Which technologies does Takeda Pharmaceutical Company Limited patent most?
C07K— PEPTIDES 116
Top 15 of 61 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Takeda Pharmaceutical Company Limited hold?
Takeda Pharmaceutical Company Limited holds 668 US granted patents filed between 2015 and 2025, spanning 61 technology areas.
What is Takeda Pharmaceutical Company Limited's Innovation Score?
Takeda Pharmaceutical Company Limited has an Innovation Score of 64.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Takeda Pharmaceutical Company Limited focus on?
Takeda Pharmaceutical Company Limited's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 535 patents. The company has filed patents in 61 CPC subclasses total.
Is Takeda Pharmaceutical Company Limited's patent filing rate increasing or decreasing?
Takeda Pharmaceutical Company Limited's recent filing velocity is +27% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Takeda Pharmaceutical Company Limited's patents?
Takeda Pharmaceutical Company Limited's patents average 13.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Takeda Pharmaceutical Company Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61P technology
Takeda Pharmaceutical Company Limited's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Takeda Pharmaceutical Company Limited ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
